Schonfeld Strategic Advisors’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,440
| Closed | -$26.6K | – | 2061 |
|
|
2024
Q2 | $26.6K | Buy |
+4,440
| New | +$26.6K | ﹤0.01% | 1852 |
|
|
2023
Q3 | – | Sell |
-6,630
| Closed | -$162K | – | 1880 |
|
|
2023
Q2 | $162K | Buy |
6,630
+1,503
| +29% | +$36.8K | ﹤0.01% | 1550 |
|
|
2023
Q1 | $160K | Sell |
5,127
-3,753
| -42% | -$117K | ﹤0.01% | 1547 |
|
|
2022
Q4 | $625K | Sell |
8,880
-3,681
| -29% | -$259K | 0.01% | 1394 |
|
|
2022
Q3 | $1.08M | Sell |
12,561
-4,989
| -28% | -$430K | 0.01% | 1196 |
|
|
2022
Q2 | $1.45M | Buy |
17,550
+11,100
| +172% | +$918K | 0.01% | 793 |
|
|
2022
Q1 | $1.07M | Buy |
6,450
+1,930
| +43% | +$321K | 0.01% | 902 |
|
|
2021
Q4 | $756K | Buy |
+4,520
| New | +$756K | 0.01% | 996 |
|